Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones

Nutrition and Cancer

Volumn 28, Issue 1, 1997, Pages 81-85

  Schmelz, Eva M ^a   Bushnev, Anatoliy S ^b   Dillehay, Dirck L ^a   Liotta, Dennis C ^b   Merrill Jr , Alfred H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; N PALMITOYLDIHYDROSPHINGOMYELIN; N PALMITOYLSPHINGOMYELIN; SPHINGOMYELIN; SPHINGOMYELIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; ELEMENTAL DIET; FEMALE; INTESTINE CRYPT; MILK; MOUSE; NONHUMAN;

ANIMALIA; SPHINGIODEA;

EID: 0030818728     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589709514556     Document Type: Article

References (43)

1. Spiegel, S, and Merrill, AH, Jr: "Sphingolipid metabolism and growth regulation." FASEB J 10, 1388-1397, 1996.
2. Schmelz, EM, Crall, KJ, Laroque, R, Dillehay, DL, and Merrill, AH, Jr: "Uptake and metabolism of sphingolipids in isolated intestinal loops." J Nutr 124, 702-712, 1994.
3. Schmelz, EM, Dillehay, DL, Webb, SK, Reiter, A, Adams, J, et al.: "Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis." Cancer Res 56, 4936-4941, 1996.
4. Dillehay, DL, Webb, SK, Schmelz, EM, and Merrill, AH, Jr: "Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice." J Nutr 124, 615-620, 1994.
5. National Research Council: Guide for the Care and Use of Laboratory Animals. Bethesda, MD: Natl Inst Health, 1985. [Publ 88-23 (rev)]
6. Garner, P, and Park, JM: "The synthesis and configurational stability of differentially protected β-hydroxy-α-amino aldehydes." J Org Chem 52, 2361-2364, 1987.
7. Garner, P, Park, JM, and Malecki, E: "A stereodivergent synthesis of D-erythro-sphingosine and D-erythro-sphinganine from L-serine." J Org Chem 53, 4395-4398, 1988.
8. Gamer, P, and Park, JM: "1,1-Dimethylethyl (S)-or (R)-4-formyl-2,2 dimethyl-3-oxazolidinecarboxylate: a useful serinal derivative." Org Synth 70, 18-28, 1991.
9. Herold, P: "Synthesis of D-erythro- and D-threo-sphingosine derivatives from L-serine." Helv Chim Acta 71, 354-362, 1988.
10. 2+-ATPaSe activator, from Symbiodinum sp." J Chem Soc Perkin Trans 1, 343-350, 1992.
11. Nimkar, S, Menaldino, D, Merrill, AH, Jr, and Liotta, DC: "A stereo-selective synthesis of sphingosine, a protein kinase C inhibitor." Tetrahedron Lett 29, 3037-3040, 1988.
12. Frantova, AY, Bushnev, AS, Zvonkova, EN, and Shvets, VI: "H-Phosphonate and phosphoramidite methods for the synthesis of phosphosphingolipids." Bioorgan Khim 17, 1562-1573, 1991. (English abstr: Chem Abstr 116, 1363, 1991)
13. Frantova, AY, Bushnev, AS, Zvonkova, EN, and Shvets, VI: "H-Phosphonate and phosphoramidite methods for the synthesis of phosphosphingolipids." Bioorgan Khim 17, 1562-1573, 1991. (English abstr: Chem Abstr 116, 1363, 1991)
14. Bruzik, KS: "Synthesis and spectral properties of chemically and stereochemically homogeneous sphingomyelin and its analogues." J Chem Soc Perkin Trans 1, 423-431, 1988.
15. Ames, BN: "Assay of inorganic phosphate, total phosphate and phosphatases." Methods Enzymol 8, 115-118, 1966.
16. American Institute of Nutrition: "Report of the American Institute of Nutrition Ad Hoc Committee on Standards for Nutrition Studies." J Nutr 107, 1340-1348, 1977.
17. Merrill, AH, Jr, Wang, E, Mullins, RE, Jamison, WCL, Nimkar, S, et al.: "Quantitation of free sphingosine in liver by high-performance liquid chromatography." Anal Chem 171, 373-381, 1988.
18. Bird, RP: "Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings." Cancer Lett 37, 147-151, 1987.
19. Hannun, YA, and Linardic, CM: "Sphingolipid breakdown products: antiproliferative and tumor suppressor lipids." Biochim Biophys Acta 1154, 223-236, 1993.
20. Zhang, H, Desai, NN, Olivera, A, Seki, T, Brooker, G, et al.: "Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation." J Cell Biol 114, 155-167, 1991.
21. Stevens, VL, Nimkar, S, Jameson, WC, Liotta, DC, and Merrill, AH, Jr: "Characteristics of the growth inhibition and cytotoxicity of long-chain (sphingoid) bases for Chinese hamster ovary cells: evidence for an involvement of protein kinase C." Biochim Biophys Acta 1051, 37-15, 1990.
22. Jayadev, S, Liu, B, Bielawska, AE, Lee, JY, Nazaire, F, et al.: "Role for ceramide in cell cycle arrest." J Biol Chem 270, 2047-2052, 1995.
23. Merrill, AH, Jr, Sereni, AM, Stevens, VL, Hannun, YA, Bell, RM, et al.: "Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases." J Biol Chem 261, 12610-12615, 1986.
24. Stevens, VL, Owens, NE, Winton, EF, Kinkade, JM, and Merrill, AH, Jr: "Modulation of retinoic acid-induced differentiation of human leukemia (HL-60) cells by serum factors and sphinganine." Cancer Res 50, 222-226, 1990.
25. Ohta, H, Sweeney, EA, Masamune, A, Yatomi, Y, Hakomori, S-I, et al.: "Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation." Cancer Res 55, 691-697, 1995.
26. Jarvis, WD, Fornari, FA, Traylor, RS, Martin, HA, Kramer, LB, et al.: "Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells." J Biol Chem 271, 8275-8284, 1996.
27. Bielawska, A, Crane, HM, Liotta, DC, Obeid, LM, and Hannun, YA: "Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide." J Biol Chem 268, 26226-26232, 1993.
28. Tepper, CL, Jayadev, S, Liu, B, Bielawska, A, Wolff, RA, et al.: "Role for ceramide as an endogenous mediator of fas-induced cytotoxicity." Proc Natl Acad Sci USA 92, 8443-8447, 1995.
29. Sawai, H, Okazaki, T, Yamamoto, H, Okano, H, Takeda, Y, et al.: "Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells." J Biol Chem 270, 27326-27331, 1995.
30. Brugg, B, Michel, PP, Agid, Y, and Ruberg, M: "Ceramide induces apoptosis in cultured mesencephalic neurons." J Neurochem 66, 733-739, 1996.
31. Karasavvas, N, Erukulla, RK, Bittman, R, Lockshin, R, and Zakeri, Z: "Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine." Eur J Biochem 236, 729-737, 1996.
32. Endo, K, Igarashi, Y, Nisar, M, Zhou, QH, and Hakomori, S-I: "Cell membrane signaling as target in cancer therapy: inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice." Cancer Res 51, 1613-1618, 1991.
33. Sweeney, EA, Sakakura, C, Shirahama, T, Masamune, A, Ohta, H, et al.: "Sphingosine and its methylated derivative N,N-dimethylsphingosine (MS) induce apoptosis in a variety of human cancer cell lines." Int J Cancer 66, 358-366, 1996.
34. Sakakura, C, Sweeney, EA, Shirahama, T, Hakomori, S-I, and Igarashi, Y: "Suppression of Bcl-2 gene expression by sphingosine in the apoptosis of human leukemic HL-60 cells during phorbol ester-induced terminal differentiation." FEBS Lett 379, 177-180, 1996.
35. Chen, M, Quintans, J, Fuks, Z, Thompson, C, Kufe, DW, et al.: "Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide." Cancer Res 55, 991-994, 1995.
36. Reynes, JG, Robayna, IG, Delgado, PS, Gonzales, IH, Aguiar, JQ, et al.: "C-jun is a downstream target for ceramide-activated protein phosphatase in A431 cells." J Biol Chem 271, 21375-21380, 1996.
37. Kim, MY, Linardic, C, Obeid, LM, and Hannun, YA: "Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α- and γ-interferon." J Biol Chem 266, 484-489, 1991.
38. Marcu, KB, Bossone, SA, and Patel, AJ: "Myc function and regulation." Annu Rev Biochem 61, 809-860, 1992.
39. Dudeja, PK, Dahiya, R, and Brasitus, TA: "The role of sphingomyelin synthase and sphingomyelinase in 1,2-dimethylhydrazine-induced lipid alterations of rat coloniC plasma membranes." Biochim Biophys Acta 863, 309-312, 1986.
40. Wright, SC, Zheng, H, and Zhong, J: "Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease." FASEB J 10, 325-332, 1996.
41. Zeisel, SH, Char, D, and Shear, NF: "Choline, phosphatidylcholine and sphingomyelin in human and bovine milk and infant formulas." J Nutr 116, 50-58, 1986.
42. Blank, ML, Cress, EA, Smith, ZL, and Snyder, NF: "Meats and fish consumed in the American diet contain substantial amounts of ether-linked phospholipids." J Nutr 122, 1656-1661, 1992.
43. Ohnishi, M, and Fujino, Y: "Sphingolipids in immature and mature soybeans." Lipids 17, 803-810, 1982.